These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 21864535)

  • 1. Promoting myelin repair and return of function in multiple sclerosis.
    Zhang J; Kramer EG; Asp L; Dutta DJ; Navrazhina K; Pham T; Mariani JN; Argaw AT; Melendez-Vasquez CV; John GR
    FEBS Lett; 2011 Dec; 585(23):3813-20. PubMed ID: 21864535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting oligodendrocyte protection and remyelination in multiple sclerosis.
    Zhang J; Kramer EG; Mahase S; Dutta DJ; Bonnamain V; Argaw AT; John GR
    Mt Sinai J Med; 2011; 78(2):244-57. PubMed ID: 21425268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogeneous remyelination: findings in human studies.
    Kipp M; Victor M; Martino G; Franklin RJ
    CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):598-609. PubMed ID: 22583436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
    Wolswijk G
    Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathology in multiple sclerosis: new concepts.
    Lassmann H
    Mult Scler; 1998 Jun; 4(3):93-8. PubMed ID: 9762654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
    J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of astrocyte - oligodendrocyte interactions in human cultures.
    John GR
    Methods Mol Biol; 2012; 814():401-14. PubMed ID: 22144322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roads to Formation of Normal Myelin Structure and Pathological Myelin Structure.
    Bando Y
    Adv Exp Med Biol; 2019; 1190():257-264. PubMed ID: 31760649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
    Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting remyelination in multiple sclerosis: current drugs and future prospects.
    Kremer D; Küry P; Dutta R
    Mult Scler; 2015 Apr; 21(5):541-9. PubMed ID: 25623245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocopherol derivative TFA-12 promotes myelin repair in experimental models of multiple sclerosis.
    Blanchard B; Heurtaux T; Garcia C; Moll NM; Caillava C; Grandbarbe L; Klosptein A; Kerninon C; Frah M; Coowar D; Baron-Van Evercooren A; Morga E; Heuschling P; Nait Oumesmar B
    J Neurosci; 2013 Jul; 33(28):11633-42. PubMed ID: 23843531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complex world of oligodendroglial differentiation inhibitors.
    Kremer D; Aktas O; Hartung HP; Küry P
    Ann Neurol; 2011 Apr; 69(4):602-18. PubMed ID: 21520230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications.
    Simkins TJ; Duncan GJ; Bourdette D
    Curr Neurol Neurosci Rep; 2021 Apr; 21(6):26. PubMed ID: 33835275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
    Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
    Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocytes--friends or foes in multiple sclerosis?
    Williams A; Piaton G; Lubetzki C
    Glia; 2007 Oct; 55(13):1300-12. PubMed ID: 17626262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.